Welcome to LookChem.com Sign In|Join Free

CAS

  • or

38184-15-5

Post Buying Request

38184-15-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

38184-15-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 38184-15-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,1,8 and 4 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 38184-15:
(7*3)+(6*8)+(5*1)+(4*8)+(3*4)+(2*1)+(1*5)=125
125 % 10 = 5
So 38184-15-5 is a valid CAS Registry Number.

38184-15-5Relevant articles and documents

A "traceless" Directing Group Enables Catalytic SN2 Glycosylation toward 1,2- cis-Glycopyranosides

Fu, Yue,Liu, Peng,Ma, Xu,Zhang, Liming,Zheng, Zhitong,Zhu, Xijun

supporting information, p. 11908 - 11913 (2021/08/20)

Generally applicable and stereoselective formation of 1,2-cis-glycopyranosidic linkage remains a long sought after yet unmet goal in carbohydrate chemistry. This work advances a strategy to this challenge via stereoinversion at the anomeric position of 1,2-trans glycosyl ester donors. This SN2 glycosylation is enabled under gold catalysis by an oxazole-based directing group optimally tethered to a leaving group and achieved under mild catalytic conditions, in mostly excellent yields, and with good to outstanding selectivities. The strategy is also applied to the synthesis of oligosaccharides.

HEPARANASE INHIBITORS AND THEIR USE AS ANTI-CANCER COMPOUNDS

-

, (2020/07/04)

Anti-heparanase compounds for the treatment of cancer are described. The anti-heparanase compounds are high affinity, synthetic glycopolymers that result in minimal anticoagulant activity. Stereoselective fluorinated forms of these compounds are also prov

A flexible 1,2-cis α-glycosylation strategy based on in situ adduct transformation

Hu, Jhe-Cyuan,Feng, Ai-Fen Wendy,Chang, Bo-Yao,Lin, Chun-Hung,Mong, Kwok-Kong Tony

, p. 5345 - 5356 (2017/07/10)

A flexible 1,2-cis α-selective glycosylation strategy for a wide range of glycosyl donors and acceptors has been developed, which is based on an in situ adduct transformation protocol. Based on this strategy, both NFM-derived and iodide covalent adducts c

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 38184-15-5